Pfizer Pregnancy Trial: COVID Vaccine Linked to 420% Surge in Newborn Abnormalities

Share it with your friends Like

Thanks! Share it with your friends!

Close

A Pfizer clinical trial on pregnant women has revealed a staggering 420% increase in congenital abnormalities and developmental delays among newborns linked to COVID vaccines, raising serious concerns about their safety during pregnancy.

The recently updated Pfizer clinical trial, “To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women” (ClinicalTrials.gov ID NCT04754594), has sparked renewed scrutiny after revealing a significant increase in congenital abnormalities among newborns of vaccinated participants.

The study assessed outcomes in 348 healthy pregnant women randomized to receive either the COVID-19 vaccine or a placebo during their third trimester. Findings indicate that children born to vaccinated mothers experienced a 4.2x higher rate of adverse events of special interest (AESIs), including major congenital abnormalities and developmental delays, within the first six months of life.

Read More

  • Rating:
  • Views:8 views
  • Categories: Health